Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

The efficacy of semax in the tretament of patients at different stages of ischemic stroke

Gusev, E. I., Martynov, M. Yu., Kostenko, E. V., Petrova, L. V., Bobyreva, S. N. · 2018 · Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova

Abstract

AIM: To evaluate the efficacy of semax and timing of rehabilitation on the dynamics of plasma BDNF levels, motor performance, and Barthel index score in patients after ischemic stroke (IS). MATERIAL AND METHODS: One hundred and ten patients after IS (43 men, 67 women, mean age 58.0±9.7, Ме 63 years) were examined. All patients were divided into early (89±9 days) and late (214±22 days) rehabilitation groups. Each group was subdivided into semax+ and semax- subgroups. Standard regimen of semax included 2 courses (6000 mcg/day) for 10 days with 20 day interval. Plasma BDNF levels, motor performance on the British Medical Research Council scale and Barthel index were assessed in all groups. RESULTS: Administration of semax, regardless of the timing of rehabilitation, increased BDNF plasma levels which remained high during the whole study period. In semax- subgroups high BDNF plasma levels were positively correlated with early rehabilitation. Administration of semax and high BDNF levels accelerated the improvement and ameliorated the final outcome of Barthel score index. There was a positive correlation between BDNF plasma levels and Barthel score, as well as a correlation between early rehabilitation and motor performance improvement. The correlation between BDNF plasma levels and Barthel score was modified by the timing of rehabilitation. CONCLUSION: Early rehabilitation and administration of semax increase BDNF plasma level, speed functional recovery, and improve motor performance.

Overview

Integrity signals

Registry

Crossref · 10.17116/jnevro20181183261-68

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Research works printed but not linked: 5

  1. Gusev EI, Skvortsova VI, Martynov MYu. Tserebralnyi insult: problemy i reshenia. Vestnik Rossiiskoi akademii nauk. 2003;11(4):44-48. (In Russ.)
  2. Kamensky AA, Myasoedov NF, Levitskaya NG, Andreeva LA, Sebentsova EA, Glazova NYu, Vilensky DA, Manchenko DM. Issledovanie spektra fiziologicheskoi aktivnosti analoga AKTG 4-10 geptapeptida Semaks. Neirokhimia. 2008;25(1-2):111-118. (In Russ.)
  3. Raevsky KS, Kudrin VS, Myasoedov NF, Grivennikov IA, Andreeva LA, Eremin KO. Vliyanie Semaksa na soderzhanie i obmen monoaminov v mozge myshei linii C57/BL. Neirokhimia. 2002;19(3):202-205. (In Russ.)
  4. Myasoedov NF, Skvorcova VI, Nasonov EL, ZHuravleva EYU, Grivennikov IA, Arsen'eva EL, Suhanov II. Izuchenie mekhanizmov nejroprotektivnogo dejstviya semaksa v ostrom periode ishemicheskogo insul'ta. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 1999;99(5):15-19. (In Russ.)
  5. Limborskaya SA, Shadrina MI, Slominskij PA, Myasoedov NF, Shram SI, Silachev DN, Agapova TYu, Agniullin YaV. Vremennaya dinamika ehkspressii genov nejrotroficheskogo faktora mozga i faktora rosta nervov v gippokampe i lobnoj kore krys pod dejstviem Semaksa. Molekulyarnaya genetika, mikrobiologiya i virusologiya. 2008;3:28-31. (In Russ.)

Cited by

See all 24

Metadata

Authors
Gusev, E. I., Martynov, M. Y., Kostenko, E. V., Petrova, L. V., & Bobyreva, S. N.
Affiliations
Pirogov Russian National Research Medical University (RU)
Venue
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova
Published
2018
Volume
118
Issue
3
Pages
61
ISSN
1997-7298 (ISSN-L)
OpenAlex
W2803355579
Cited by
24
References
26
Citations by year
2026: 2 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 3 · 2021: 8 · 2020: 1 · 2019: 1
FWCI
2.14
Type
journal article
Language
en
Open access
closed
Locations
  • S S Korsakov Journal of Neurology and Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
  • Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords
Semax, ischemic stroke, brain-derived neurotrophic factor, early rehabilitation, rehabilitation timing, motor performance, functional recovery, Barthel Index, plasma BDNF levels, stroke rehabilitation
MeSH terms
Stroke Rehabilitation, Adrenocorticotropic Hormone, Aged, Brain Ischemia, Female, Humans, Male, Middle Aged, Peptide Fragments, Brain-Derived Neurotrophic Factor, Stroke

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The efficacy of semax in the tretament of patients at different stages of ischemic stroke. https://app.cochat.ai/papers/10.17116/jnevro20181183261-68
The paper
Gusev, E. I., Martynov, M. Y., Kostenko, E. V., Petrova, L. V., & Bobyreva, S. N. (2018). The efficacy of semax in the tretament of patients at different stages of ischemic stroke. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. https://doi.org/10.17116/jnevro20181183261-68

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.